HomeTagsReal estate

real estate

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
spot_img
SGX-LISTED COMPANIES

LHN Limited’s 1H FY2026 Profit Surge Showcases Exceptional Capital Efficiency

Less is More In equity research, we are conditioned to view top-line contraction as a...
SGX-LISTED COMPANIES

The 77% Profit Surge At Frasers Property Everyone Missed In 1H FY2026

4 Surprising Takeaways from Frasers Property’s 1H FY2026 Results The global real estate market is...
SGX-LISTED COMPANIES

AIMS APAC REIT FY2026 Portfolio Rejuvenation

5 Surprising Takeaways from AIMS APAC REIT’s FY2026 Results AIMS APAC REIT recently released its...
SGX-LISTED COMPANIES

Why Mapletree Industrial Trust’s Data Center Pivot Is The Real Story Of Q4 & FY25/26

The REIT Reality Check The current landscape for industrial Real Estate Investment Trusts (REITs) is...
SGX-LISTED COMPANIES

Mapletree Pan Asia Commercial Trust Deliberately Shrinks In Q4 FY2026

Why “Shrinking” is the New Path to Resilience In the current global economic landscape, investors...
SGX-LISTED COMPANIES

Why Falling Housing & Development Board Prices Might Actually Be Good For Singapore Property

The Resilience of the Home Buyer The global landscape in the first quarter of 2026...
SGX-LISTED COMPANIES

How Tosei’s Defiant Q1 2026 Reframes Tokyo’s Property Narrative

Introduction In the corridors of global finance, the prevailing sentiment regarding Japanese real estate has...
SGX-LISTED COMPANIES

Thakral Corporation FY2025 Sees A S$174 Million Surge

Why Losing Influence in GemLife Was Thakral’s Strategic Masterstroke Sophisticated retail investors often find themselves...
SGX-LISTED COMPANIES

Manulife US REIT FY2025 Survival Plan

https://open.spotify.com/episode/0Q7vFX5d2rhOFfaBUXy8dN?si=26dcc38470b84a9d How Manulife US REIT is Rebuilding for a Diversified Future Navigating the US Office Landscape The...
SGX-LISTED COMPANIES

UI Boustead REIT’s IPO – Are They Redefining The Industrial Playbook?

https://open.spotify.com/episode/1FRSiKbovzXyNjGCT9b931?si=6b335927b60f498d 5 Reasons UI Boustead REIT is Redefining the Industrial Playbook For the uninitiated, industrial real...
SGX-LISTED COMPANIES

How City Developments Tripled Profits In FY2025

https://open.spotify.com/episode/1QIw0KqIt9MndVfBDgJ9bq?si=ab425a905ba54eb7 The Asset-Light Coup: Inside CDL’s $2 Billion Capital Recycling Masterclass The 2025 fiscal landscape was...
SGX-LISTED COMPANIES

Singapore Land’s Massive FY2025 Sydney Move

https://open.spotify.com/episode/6f08AonwL5YmfCa6dad1mS?si=89f0a8a1e4194aea To the casual observer, Singapore Land Group Limited’s (SingLand) FY2025 results present a riddle....
Load more

Latest articles

SGX-LISTED COMPANIES

Top Glove Q3 FY2026 Earnings Rise Despite Fluctuating Material Costs

Resilient Growth and Strategic Agility Top Glove Corporation has reported a remarkable 138% year-on-year surge...
Pharmaceutical

AstraZeneca invests US$20M to curb Malaysia chronic disease burden

AstraZeneca is scaling up early screening and clinical research efforts in Malaysia as the...
Pharmaceutical

AstraZeneca expands diagnostics and AI to tackle late-stage cancer deaths

AstraZeneca is sharpening its long-term AstraZeneca cancer strategy with a combination of heavy research...
Pharmaceutical

AstraZeneca deploys AI to cut drug timelines by 30% and boost survival

AstraZeneca is stepping up its investment in AI drug discovery to shorten treatment timelines...